Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 159,194 | 127,722 | 135,590 | 119,027 | 130,974 |
| Cost of Goods | 39,007 | 34,651 | 35,248 | 31,349 | 35,298 |
| Gross Profit | 120,187 | 93,071 | 100,342 | 87,678 | 95,676 |
| Operating Expenses | 115,983 | 62,289 | 65,747 | 68,590 | 77,191 |
| Operating Income | 4,211 | 31,433 | 34,843 | 19,437 | 18,783 |
| Interest Expense | 10,423 | 7,333 | 7,023 | 6,971 | 7,061 |
| Other Income | 13 | 131 | -2,172 | 258 | 971 |
| Pre-tax Income | -6,199 | 24,231 | 25,648 | 12,724 | 12,693 |
| Income Tax | -1,069 | 6,571 | 6,567 | 2,355 | -1,821 |
| Net Income Continuous | -5,130 | 17,660 | 19,081 | 10,369 | 14,514 |
| Net Income | $-5,130 | $17,660 | $19,081 | $10,369 | $14,514 |
| EPS Basic Total Ops | -0.12 | 0.40 | 0.43 | 0.24 | 0.36 |
| EPS Basic Continuous Ops | -0.12 | 0.40 | 0.43 | 0.24 | 0.36 |
| EPS Diluted Total Ops | -0.12 | 0.39 | 0.42 | 0.23 | 0.37 |
| EPS Diluted Continuous Ops | -0.11 | 0.39 | 0.42 | 0.23 | 0.37 |
| EBITDA(a) | $23,966 | $43,673 | $46,143 | $30,596 | $30,058 |